“Breast Cancer Talk”: Nursing Perspectives on HER2-Targeted Agents in Breast Cancer - Episode 1

Practical Management of Early Stage HER2+ Breast Cancer

September 23, 2020
Madelaine Kuiper, NP, UCLA Santa Monica Hematology/Oncology

Loyda E. Braithwaite, NP, University of Wisconsin Carbone Cancer Center

Susan Hays, ANP, Washington University Siteman Cancer Center

Elahe Salehi, DNP, ANP-BC, Dana-Farber Cancer Institute

Nurse practitioners provide insight on issues surrounding the administration of dual HER2-targeted therapy in the neoadjuvant/adjuvant setting and counseling patients on common AEs associated with trastuzumab-pertuzumab for the treatment of HER2+ breast cancer.